Healthcare · Drug Manufacturers General · NYSE
| Market cap | $208.92B |
|---|---|
| Trailing P/E | 13.1 |
| FCF yield | 2.1% |
| Revenue growth (YoY) | +6.4% |
| EPS growth (YoY) | +1.8% |
| FCF/share growth (YoY) | -58.2% |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | Drug Manufacturers General |
Novo Nordisk A/S trades disclosed by members of the US House and Senate under the STOCK Act. See the full Congress trades board →
| Member | Chamber | Trade | Amount | Disclosed |
|---|---|---|---|---|
| Lisa McClain | House | Sell | $1,001 - $15,000 | Nov 1, 2025 |
| Lisa McClain | House | Sell | $1,001 - $15,000 | Nov 1, 2025 |
| Lisa McClain | House | Buy | $1,001 - $15,000 | Oct 1, 2025 |
| Valerie Hoyle | House | Buy | $1,001 - $15,000 | Sep 11, 2025 |
| Marjorie Taylor Greene | House | Buy | $15,001 | Aug 20, 2025 |
| Lisa McClain | House | Buy | $1,001 - $15,000 | Aug 13, 2025 |
| Scott Scott Franklin | House | Buy | $1,001 - $15,000 | Aug 5, 2025 |
| Scott Scott Franklin | House | Buy | $15,001 - $50,000 | Aug 5, 2025 |
| Scott Scott Franklin | House | Buy | $15,001 - $50,000 | Apr 7, 2025 |
| Byron Donalds | House | Sell | $1,001 - $15,000 | Apr 7, 2025 |
| Daniel Goldman | House | Sell | $100,001 - | Aug 9, 2023 |
| Katherine M. Clark | House | Sell | $1,001 - $15,000 | Oct 13, 2021 |